Effectiveness of bivalent mRNA vaccines against medically attended symptomatic SARS-CoV-2 infection and COVID-19-related hospital admission among SARS-CoV-2-naive and previously infected individuals: a retrospective cohort study-Reference-Cited by-同舟云学术

Effectiveness of bivalent mRNA vaccines against medically attended symptomatic SARS-CoV-2 infection and COVID-19-related hospital admission among SARS-CoV-2-naive and previously infected individuals: a retrospective cohort study

Published:2023-12 Issue:12 Volume:23 Page:1343-1348
ISSN:1473-3099
Container-title:The Lancet Infectious Diseases
language:en
Short-container-title:The Lancet Infectious Diseases

Author:

Tan Celine Y,Chiew Calvin J,Pang Deanette,Lee Vernon J,Ong Benjamin,Wang Lin-Fa,Ren Ee Chee,Lye David Chien,Tan Kelvin Bryan

Publisher

Elsevier BV

Subject

Infectious Diseases

Reference23 articles.

1. Reduced neutralisation of SARS-CoV-2 omicron B.1.1.529 variant by post-immunisation serum;Dejnirattisai;Lancet,2022

2. Immune escape associated with RBD omicron mutations and SARS-CoV-2 evolution dynamics;Kudriavtsev;Viruses,2022

3. Evolution of the SARS-CoV-2 omicron variants BA.1 to BA.5: implications for immune escape and transmission;Shrestha;Rev Med Virol,2022

4. Vaccine effectiveness against SARS-CoV-2 infection or COVID-19 hospitalization with the alpha, delta, or omicron SARS-CoV-2 variant: a nationwide Danish cohort study;Gram;PLoS Med,2022

5. Clinical severity of, and effectiveness of mRNA vaccines against, COVID-19 from omicron, delta, and alpha SARS-CoV-2 variants in the United States: prospective observational study;Lauring;BMJ,2022

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. COVID-19 vaccine updates for people under different conditions;Science China Life Sciences;2024-07-29

2. Randomized controlled trial reveals no benefit to a 3-month delay in COVID-19 mRNA booster vaccine;Journal of Clinical Investigation;2024-07-11

3. Risks of Severe Acute Respiratory Syndrome Coronavirus 2 JN.1 Infection and Coronavirus Disease 2019–Associated Emergency Department Visits/Hospitalizations Following Updated Boosters and Prior Infection: A Population-Based Cohort Study;Clinical Infectious Diseases;2024-06-26

4. Effectiveness of the fourth dose of COVID-19 vaccines against severe COVID-19 among adults 40 years or older in Brazil: a population-based cohort study;The Lancet Regional Health - Americas;2024-06

5. Neutralization of EG.5, EG.5.1, BA.2.86, and JN.1 by antisera from dimeric receptor-binding domain subunit vaccines and 41 human monoclonal antibodies;Med;2024-05